Outcome of Kasai Portoenterostomy in Biliary Atresia in Upper Egypt

Status Completed

Clinical Trial Summary

Kasai portoenterostomy is the key standard operation for biliary atresia. The aim of the study is to evaluate the short-term outcome of Kasai portoenterostomy for biliary atresia infants in Upper Egypt.

Clinical Trial Description

It is a cross-sectional retrospective multicenter study from Upper Egypt. The data will collected from the medical records of three university hospitals in Upper Egypt from January 2019 to December 2019. Inclusion and exclusion criteria Inclusion criteria included all neonates diagnosed with biliary atresia in the previous period and managed by Kasai portoenterostomy. Exclusion criteria were neonates without a confirmed diagnosis of biliary atresia. ;

Study Design

Related Conditions & MeSH terms

Biliary Atresia

Clinical Trial Details

NCT number	NCT05925543
Study type	Observational
Source	Aswan University Hospital
Contact
Status	Completed
Phase
Start date	January 1, 2019
Completion date	December 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT03667534` - Dry Blood Spot Screening Test for Neonatal Cholestasis Patients
Completed	`NCT02652533` - Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia
Completed	`NCT01443572` - The Comparison of Desflurane and Sevoflurane on Postoperative Recovery and Hepatic Function of Biliary Atresia Patients During Kasai Operation	N/A
Recruiting	`NCT04373941` - Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia	Phase 2
Completed	`NCT01854827` - Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia	Phase 1/Phase 2
Completed	`NCT00007033` - Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease	N/A
Recruiting	`NCT05848310` - Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
Recruiting	`NCT05072626` - High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
Completed	`NCT02292862` - Maternal Microchimerism in Lymph Nodes of Infants With Biliary Atresia at Time of Kasai's Operation	N/A
Completed	`NCT00294684` - A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following Portoenterostomy	N/A
Active, not recruiting	`NCT02922751` - FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Recruiting	`NCT04260503` - Gut Microbiome in Biliary Atresia
Not yet recruiting	`NCT06260566` - Tolerability of Enteral NAC in Infants	Phase 1
Completed	`NCT01322386` - Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin	Phase 1
Recruiting	`NCT05909033` - Early Predictors for the Short Term Native Liver Survival in Patients With Biliary Atresia After Kasai Procedure
Completed	`NCT03499249` - N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy	Phase 2
Recruiting	`NCT00345553` - Biliary Atresia Study in Infants and Children
Recruiting	`NCT05521152` - Norepinephrine for Prevention of Intraoperative Hypotension in Infants Undergoing Kasai Portoenterostomy	Phase 3
Not yet recruiting	`NCT05783518` - Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients	Phase 4
Not yet recruiting	`NCT06121375` - Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy	Phase 2/Phase 3